Cipla balance sheet

As of Sep 2026

Total assets: ₹43,434cr+8.1% on Sep 2025
Shareholders' equity: ₹35,522cr+7.6% on Sep 2025
Total debt: ₹267cr+183.7% on Sep 2025
Cash and investments: ₹7,793cr−6.1% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	6,555	6,040	5,262	5,069	4,991
	1,711	1,586	1,213	864	689
	0.0	0.0	111	114	59.8
	3,854	3,754	3,270	3,112	2,984
	2,649	2,640	1,363	1,313	1,126
	603	456	354	288	404
	106	112	140	130	90.9
	446	432	499	512	482
	1.5	2.8	32.5	17.0	0.0
	187	1,194	283	509	99.3
	634	1,629	815	1,038	581
	967	901	645	588	457
	1,293	1,231	925	761	806
	18,372	18,349	14,099	13,276	12,188
	6,778	6,597	5,642	5,238	5,156
	6,134	7,679	7,293	4,807	3,090
	6,000	5,620	5,506	4,771	4,057
	1,659	1,018	589	640	628
	445	289	211	235	937
	27.2	23.1	15.6	0.2	7.6
	2,391	1,460	2,937	2,802	2,081
	16,656	16,090	16,552	13,254	10,800
	1,626	1,459	1,055	900	849
	25,061	24,146	23,249	19,392	16,805
	1.2	1.2	39.6	49.0	470
	43,434	42,496	37,387	32,718	29,463
Equity
	162	162	162	161	161
	35,234	34,270	31,032	26,545	23,246
	35,396	34,432	31,193	26,706	23,408
	127	88.3	95.8	95.9	306
	35,522	34,520	31,289	26,802	23,714
Liabilities
	131	117	12.0	0.0	0.0
	505	485	343	293	323
	636	602	355	293	323
	150	158	149	129	102
	96.4	153	53.5	185	163
	52.9	49.0	56.8	61.9	52.1
	935	962	614	670	640
	136	141	80.1	247	520
	3,266	3,230	2,837	2,474	2,457
	993	1,078	480	579	468
	4,396	4,448	3,398	3,300	3,446
	2,137	2,259	1,717	1,612	1,287
	127	5.5	76.8	22.0	16.6
	317	301	293	312	284
	6,977	7,014	5,484	5,246	5,033
	—	—	0.0	0.0	76.4
	7,912	7,976	6,098	5,915	5,750
	43,434	42,496	37,387	32,718	29,463
Trade payables — MSME split
	220	215	279	254	226
	3,046	3,015	2,559	2,220	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CIPLA₹1,365.60

Cipla Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA DRREDDY LUPIN APOLLOHOSP MAXHEALTH DIVISLAB TORNTPHARM ZYDUSLIFEMcap ₹1.10L Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	4,990.8	5,069.0	5,262.3	6,039.8	6,554.6
+ Capital Work-in-Progress	689.2	864.3	1,212.8	1,586.3	1,711.4
+ Investment Property	59.8	113.6	111.3	0.0	0.0
+ Goodwill	2,983.9	3,112.0	3,270.3	3,754.4	3,854.4
+ Other Intangibles	1,126.0	1,312.6	1,362.6	2,640.1	2,648.9
+ Intangibles under Development	404.1	288.4	353.5	455.9	603.5
+ Investments (Equity Method)	90.9	130.1	140.5	111.8	105.9
+ Non-current Investments	481.6	512.2	499.1	432.2	445.6
+ Long-term Loans	0.0	17.0	32.5	2.8	1.5
+ Other Non-current Financial Assets	99.3	508.6	283.5	1,194.1	187.3
Non-current Financial Assets	580.9	1,037.7	815.1	1,629.1	634.4
+ Deferred Tax Assets	456.5	587.8	644.9	901.0	966.6
+ Other Non-current Assets	806.2	760.9	925.5	1,230.5	1,292.7
Total Non-current Assets	12,188.3	13,276.4	14,098.5	18,349.0	18,372.4
Current Assets
+ Inventories	5,156.4	5,238.0	5,642.1	6,596.7	6,778.4
+ Current Investments	3,089.9	4,807.0	7,293.2	7,679.4	6,134.1
+ Trade Receivables	4,057.0	4,770.7	5,506.4	5,620.1	5,999.9
+ Cash & Cash Equivalents	627.6	640.1	588.7	1,018.2	1,659.2
+ Other Bank Balances	937.0	234.9	211.2	289.2	445.0
+ Short-term Loans	7.6	0.2	15.6	23.1	27.2
+ Other Current Financial Assets	2,080.6	2,801.5	2,936.9	1,460.2	2,390.5
Current Financial Assets	10,799.6	13,254.4	16,552.0	16,090.2	16,655.9
+ Other Current Assets	849.0	900.1	1,054.9	1,458.9	1,626.4
Total Current Assets	16,805.1	19,392.5	23,249.0	24,145.9	25,060.8
+ Assets Held for Sale	469.9	49.0	39.6	1.2	1.2
Total Assets	29,463.3	32,717.8	37,387.0	42,496.0	43,434.3
Equity
+ Equity Share Capital	161.4	161.5	161.5	161.6	161.6
+ Other Equity / Reserves	23,246.4	26,545.0	31,031.9	34,270.4	35,233.9
Equity — Owners of Parent	23,407.8	26,706.4	31,193.5	34,432.0	35,395.5
+ Minority Interest	305.8	95.9	95.8	88.3	126.7
Total Equity	23,713.5	26,802.3	31,289.3	34,520.2	35,522.2
Liabilities
+ Borrowings — Non-current	0.0	0.0	12.0	117.5	131.1
+ Other Non-current Financial Liab	322.5	293.2	342.9	484.9	505.1
Non-current Financial Liabilities	322.5	293.2	354.9	602.4	636.3
+ Provisions — Non-current	102.2	129.3	148.7	157.6	149.7
+ Deferred Tax Liabilities	163.3	185.3	53.5	153.3	96.4
+ Other Non-current Liabilities	52.1	61.9	56.8	49.0	52.9
Non-current Liabilities	640.1	669.7	613.8	962.2	935.2
+ Borrowings — Current	520.4	247.0	80.1	140.5	136.3
+ Trade Payables	2,457.1	2,474.0	2,837.5	3,229.9	3,266.0
+ Other Current Financial Liab	468.5	579.1	480.1	1,078.1	993.3
Current Financial Liabilities	3,445.9	3,300.1	3,397.8	4,448.5	4,395.6
+ Provisions — Current	1,286.7	1,611.8	1,716.6	2,259.2	2,136.9
+ Current Tax Liabilities	16.6	22.0	76.8	5.5	127.3
+ Other Current Liabilities	284.1	311.9	292.9	300.5	317.2
Current Liabilities	5,033.3	5,245.8	5,484.0	7,013.6	6,976.9
+ Liabilities Held for Sale	76.4	0.0	0.0	—	—
Total Liabilities	5,749.7	5,915.5	6,097.8	7,975.7	7,912.1
Total Equity & Liabilities	29,463.3	32,717.8	37,387.0	42,496.0	43,434.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	225.9	253.5	278.6	215.2	219.9
+ Dues to Other Creditors — Current	—	2,220.4	2,558.9	3,014.7	3,046.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.